APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gliclazide Sustained-release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gliclazide Sustained-release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchGliclazide Sustained-release Tablet Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gliclazide Sustained-release Tablet Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gliclazide Sustained-release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gliclazide Sustained-release Tablet Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gliclazide Sustained-release Tablet Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gliclazide Sustained-release Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gliclazide Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gliclazide Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gliclazide Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gliclazide Sustained-release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gliclazide Sustained-release Tablet include Yiling Pharmaceutical, Teva, Shijiazhuang SIYAO, Sanofi S.A., Mylan Pharmaceuticals, Lukang Jituan Saite Yaoye, Zydus Cadila Healthcare, Torrent Pharmaceuticals and Servier Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Gliclazide Sustained-release Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gliclazide Sustained-release Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gliclazide Sustained-release Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gliclazide Sustained-release Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Gliclazide Sustained-release Tablet Segment by Company

Yiling Pharmaceutical

Teva

Shijiazhuang SIYAO

Sanofi S.A.

Mylan Pharmaceuticals

Lukang Jituan Saite Yaoye

Zydus Cadila Healthcare

Torrent Pharmaceuticals

Servier Laboratories

Aurobindo Pharma

Accord Healthcare

Gliclazide Sustained-release Tablet Segment by Type

30mg

60mg

Other

Gliclazide Sustained-release Tablet Segment by Application

Hospital

Clinic

Other

Gliclazide Sustained-release Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliclazide Sustained-release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gliclazide Sustained-release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliclazide Sustained-release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gliclazide Sustained-release Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gliclazide Sustained-release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Gliclazide Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Gliclazide Sustained-release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Gliclazide Sustained-release Tablet Industry Trends Table 2. Gliclazide Sustained-release Tablet Industry Drivers Table 3. Gliclazide Sustained-release Tablet Industry Opportunities and Challenges Table 4. Gliclazide Sustained-release Tablet Industry Restraints Table 5. Global Gliclazide Sustained-release Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Gliclazide Sustained-release Tablet Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers Table 9. Global Gliclazide Sustained-release Tablet Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Gliclazide Sustained-release Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gliclazide Sustained-release Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gliclazide Sustained-release Tablet Manufacturers, Product Type & Application Table 13. Global Gliclazide Sustained-release Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gliclazide Sustained-release Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 30mg Table 17. Major Manufacturers of 60mg Table 18. Major Manufacturers of Other Table 19. Global Gliclazide Sustained-release Tablet Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 21. Global Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 22. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2026) Table 23. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2027-2032) Table 24. Global Gliclazide Sustained-release Tablet Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (k units) Table 26. Global Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (k units) Table 27. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2026) Table 28. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global Gliclazide Sustained-release Tablet Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 34. Global Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 35. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2026) Table 36. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2027-2032) Table 37. Global Gliclazide Sustained-release Tablet Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (k units) Table 39. Global Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (k units) Table 40. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2026) Table 41. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2027-2032) Table 42. Global Gliclazide Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Gliclazide Sustained-release Tablet Sales by Region (2021-2026) & (k units) Table 44. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2021-2026) Table 45. Global Gliclazide Sustained-release Tablet Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Gliclazide Sustained-release Tablet Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 49. North America Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 50. Europe Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 52. Europe Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 59. Global Gliclazide Sustained-release Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Gliclazide Sustained-release Tablet Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Gliclazide Sustained-release Tablet Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2021-2026) Table 63. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2027-2032) Table 64. Yiling Pharmaceutical Company Information Table 65. Yiling Pharmaceutical Business Overview Table 66. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio Table 68. Yiling Pharmaceutical Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Gliclazide Sustained-release Tablet Product Portfolio Table 73. Teva Recent Development Table 74. Shijiazhuang SIYAO Company Information Table 75. Shijiazhuang SIYAO Business Overview Table 76. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio Table 78. Shijiazhuang SIYAO Recent Development Table 79. Sanofi S.A. Company Information Table 80. Sanofi S.A. Business Overview Table 81. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio Table 83. Sanofi S.A. Recent Development Table 84. Mylan Pharmaceuticals Company Information Table 85. Mylan Pharmaceuticals Business Overview Table 86. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio Table 88. Mylan Pharmaceuticals Recent Development Table 89. Lukang Jituan Saite Yaoye Company Information Table 90. Lukang Jituan Saite Yaoye Business Overview Table 91. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio Table 93. Lukang Jituan Saite Yaoye Recent Development Table 94. Zydus Cadila Healthcare Company Information Table 95. Zydus Cadila Healthcare Business Overview Table 96. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio Table 98. Zydus Cadila Healthcare Recent Development Table 99. Torrent Pharmaceuticals Company Information Table 100. Torrent Pharmaceuticals Business Overview Table 101. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio Table 103. Torrent Pharmaceuticals Recent Development Table 104. Servier Laboratories Company Information Table 105. Servier Laboratories Business Overview Table 106. Servier Laboratories Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio Table 108. Servier Laboratories Recent Development Table 109. Aurobindo Pharma Company Information Table 110. Aurobindo Pharma Business Overview Table 111. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio Table 113. Aurobindo Pharma Recent Development Table 114. Accord Healthcare Company Information Table 115. Accord Healthcare Business Overview Table 116. Accord Healthcare Gliclazide Sustained-release Tablet Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio Table 118. Accord Healthcare Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Gliclazide Sustained-release Tablet Distributors List Table 122. Gliclazide Sustained-release Tablet Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Gliclazide Sustained-release Tablet Product Image Figure 2. Global Gliclazide Sustained-release Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gliclazide Sustained-release Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Gliclazide Sustained-release Tablet Sales (2021-2032) & (k units) Figure 5. Global Gliclazide Sustained-release Tablet Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Gliclazide Sustained-release Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 30mg Image Figure 9. 60mg Image Figure 10. Other Image Figure 11. Global Gliclazide Sustained-release Tablet Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Gliclazide Sustained-release Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2032) Figure 14. Global Gliclazide Sustained-release Tablet Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Gliclazide Sustained-release Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Gliclazide Sustained-release Tablet Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Gliclazide Sustained-release Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2032) Figure 23. Global Gliclazide Sustained-release Tablet Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Gliclazide Sustained-release Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2032) Figure 26. North America Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Gliclazide Sustained-release Tablet Sales Market Share by Country (2021-2032) Figure 28. U.S. Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country (2021-2032) Figure 33. Germany Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Gliclazide Sustained-release Tablet Sales Market Share by Country (2021-2032) Figure 40. China Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales Market Share by Country (2021-2032) Figure 48. Brazil Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Gliclazide Sustained-release Tablet Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Gliclazide Sustained-release Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Figure 59. North America Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Figure 61. Europe Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Gliclazide Sustained-release Tablet Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Gliclazide Sustained-release Tablet Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yiling Pharmaceutical
  • Teva
  • Shijiazhuang SIYAO
  • Sanofi S.A.
  • Mylan Pharmaceuticals
  • Lukang Jituan Saite Yaoye
  • Zydus Cadila Healthcare
  • Torrent Pharmaceuticals
  • Servier Laboratories
  • Aurobindo Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gliclazide Sustained-release Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gliclazide Sustained-release Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Gliclazide Sustained-release Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Gliclazide Sustained-release Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Gliclazide Sustained-release Tablet Market Dynamics
  1. 2.1 Gliclazide Sustained-release Tablet Industry Trends
  2. 2.2 Gliclazide Sustained-release Tablet Industry Drivers
  3. 2.3 Gliclazide Sustained-release Tablet Industry Opportunities and Challenges
  4. 2.4 Gliclazide Sustained-release Tablet Industry Restraints
3 Gliclazide Sustained-release Tablet Market by Manufacturers
  1. 3.1 Global Gliclazide Sustained-release Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Gliclazide Sustained-release Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Gliclazide Sustained-release Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Gliclazide Sustained-release Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gliclazide Sustained-release Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gliclazide Sustained-release Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Gliclazide Sustained-release Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gliclazide Sustained-release Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gliclazide Sustained-release Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gliclazide Sustained-release Tablet Tier 1, Tier 2, and Tier 3
4 Gliclazide Sustained-release Tablet Market by Type
  1. 4.1 Gliclazide Sustained-release Tablet Type Introduction
  2. 4.1.1 30mg
  3. 4.1.2 60mg
  4. 4.1.3 Other
  5. 4.2 Global Gliclazide Sustained-release Tablet Sales by Type
  6. 4.2.1 Global Gliclazide Sustained-release Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  8. 4.2.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2032)
  9. 4.3 Global Gliclazide Sustained-release Tablet Revenue by Type
  10. 4.3.1 Global Gliclazide Sustained-release Tablet Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  12. 4.3.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2032)
5 Gliclazide Sustained-release Tablet Market by Application
  1. 5.1 Gliclazide Sustained-release Tablet Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Gliclazide Sustained-release Tablet Sales by Application
  6. 5.2.1 Global Gliclazide Sustained-release Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Gliclazide Sustained-release Tablet Revenue by Application
  10. 5.3.1 Global Gliclazide Sustained-release Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2032)
6 Global Gliclazide Sustained-release Tablet Sales by Region
  1. 6.1 Global Gliclazide Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gliclazide Sustained-release Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Gliclazide Sustained-release Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Gliclazide Sustained-release Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gliclazide Sustained-release Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gliclazide Sustained-release Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Gliclazide Sustained-release Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Gliclazide Sustained-release Tablet Revenue by Region
  1. 7.1 Global Gliclazide Sustained-release Tablet Revenue by Region
  2. 7.1.1 Global Gliclazide Sustained-release Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Gliclazide Sustained-release Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Gliclazide Sustained-release Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Gliclazide Sustained-release Tablet Revenue (2021-2032)
  8. 7.2.2 North America Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Gliclazide Sustained-release Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Gliclazide Sustained-release Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Gliclazide Sustained-release Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Gliclazide Sustained-release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yiling Pharmaceutical
  2. 8.1.1 Yiling Pharmaceutical Company Information
  3. 8.1.2 Yiling Pharmaceutical Business Overview
  4. 8.1.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio
  6. 8.1.5 Yiling Pharmaceutical Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Gliclazide Sustained-release Tablet Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Shijiazhuang SIYAO
  14. 8.3.1 Shijiazhuang SIYAO Company Information
  15. 8.3.2 Shijiazhuang SIYAO Business Overview
  16. 8.3.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio
  18. 8.3.5 Shijiazhuang SIYAO Recent Developments
  19. 8.4 Sanofi S.A.
  20. 8.4.1 Sanofi S.A. Company Information
  21. 8.4.2 Sanofi S.A. Business Overview
  22. 8.4.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio
  24. 8.4.5 Sanofi S.A. Recent Developments
  25. 8.5 Mylan Pharmaceuticals
  26. 8.5.1 Mylan Pharmaceuticals Company Information
  27. 8.5.2 Mylan Pharmaceuticals Business Overview
  28. 8.5.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
  30. 8.5.5 Mylan Pharmaceuticals Recent Developments
  31. 8.6 Lukang Jituan Saite Yaoye
  32. 8.6.1 Lukang Jituan Saite Yaoye Company Information
  33. 8.6.2 Lukang Jituan Saite Yaoye Business Overview
  34. 8.6.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio
  36. 8.6.5 Lukang Jituan Saite Yaoye Recent Developments
  37. 8.7 Zydus Cadila Healthcare
  38. 8.7.1 Zydus Cadila Healthcare Company Information
  39. 8.7.2 Zydus Cadila Healthcare Business Overview
  40. 8.7.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio
  42. 8.7.5 Zydus Cadila Healthcare Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Servier Laboratories
  50. 8.9.1 Servier Laboratories Company Information
  51. 8.9.2 Servier Laboratories Business Overview
  52. 8.9.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio
  54. 8.9.5 Servier Laboratories Recent Developments
  55. 8.10 Aurobindo Pharma
  56. 8.10.1 Aurobindo Pharma Company Information
  57. 8.10.2 Aurobindo Pharma Business Overview
  58. 8.10.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio
  60. 8.10.5 Aurobindo Pharma Recent Developments
  61. 8.11 Accord Healthcare
  62. 8.11.1 Accord Healthcare Company Information
  63. 8.11.2 Accord Healthcare Business Overview
  64. 8.11.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio
  66. 8.11.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gliclazide Sustained-release Tablet Value Chain Analysis
  2. 9.1.1 Gliclazide Sustained-release Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gliclazide Sustained-release Tablet Production Mode & Process
  6. 9.2 Gliclazide Sustained-release Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gliclazide Sustained-release Tablet Distributors
  9. 9.2.3 Gliclazide Sustained-release Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst